Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
Canadian Journal of Kidney Health and Disease|April 23, 2021
Defining the Scope of Knowledge Translation Within a National, Patient-Oriented Kidney Research NetworkMeghan J Elliott, Selina Allu, Mary Beaucage, et al.Journal of Gastrointestinal Oncology|September 12, 2017
The role of induction chemotherapy + chemoradiotherapy in localised pancreatic cancer: initial experience in ScotlandDerek Grose, David McIntosh, Nigel Jamieson, et al.Journal of Clinical Medicine|July 2, 2021
Effect of Hepatocellular Carcinoma Surveillance Programmes on Overall Survival in a Mixed Cirrhotic UK Population: A Prospective, Longitudinal Cohort StudyMohammad Inamul Haq, Thomas M Drake, Tee Lin Goh, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2025
FOLFIRINOX or FOLFOX for locally advanced or metastatic small bowel adenocarcinoma: PRODIGE 86 - FFCD-GONO - ENGIC 02 - FOLFIRINOX SBA phase II randomized trialThomas Aparicio, Anthony Turpin, Aziz Zaanan, et al.Clinical Trials (London, England)|January 27, 2022
Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancerLouise C Brown, Janet Graham, David Fisher, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 12, 2020
KDOQI Clinical Practice Guideline for Vascular Access: 2019 UpdateCharmaine E Lok, Thomas S Huber, Timmy Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2023
ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAFV600E-Mutant Metastatic Colorectal CancerEric Van Cutsem, Julien Taieb, Rona Yaeger, et al.The Journal of Pathology. Clinical Research|May 14, 2020
Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancerAntonia K Roseweir, James H Park, Sanne Ten Hoorn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2021
Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N TrialRichard A Adams, David J Fisher, Janet Graham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2021
Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active MonitoringJenny F Seligmann, David J Fisher, Louise C Brown, et al.Pageof 7